NASDAQ : GRML

Greenland Mines Ltd — Company profile

United States

Last price 5.14 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 68.60M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Company profile

Greenland Mines Ltd engages in the cell and gene therapy, and natural resources businesses. The company primarily explores palladium, gold, and platinum deposits. It focuses on the exploration and development of Skaergaard project located in Southeast Greenland and the Sarartoq neodymium-praseodymium (Nd-Pr) rare earths project in Southwest Greenland. The company is also involved in the development of KLTO-202, a gene therapy for the treatment and prevention of amyotrophic lateral sclerosis; and KLTO-101 for the treatment or prevention of Alzheimer’s disease, as well as therapies to treat Parkinson’s and other age-related disorders. The company was formerly known as Klotho Neurosciences, Inc. and changed its name to Greenland Mines Ltd in March 2026. Greenland Mines Ltd is based in Charlotte, North Carolina.

Details

NameGreenland Mines Ltd
SectorMaterials
IndustryOther Precious Metals & Mining
Employees5
CeoJoseph Sinkule
CountryUnited States
ExchangeNASDAQ
Fiscal YearJanuary - December
Reporting CurrencyUSD
IsinUS49876K2024
Cusip49876K202
Cik0001907223

Key executives

NameTitle
Dr. Joseph A. Sinkule Pharm.D.Founder, Chief Executive Officer, Chairman of the Board and Secretary
Jeffrey LeBlancChief Financial Officer
Peter J. MoriartyChief Business Officer
Dr. Bo Moller StensgaardPresident
Dr. Miguel Chillon RodriguezChief Scientific Officer and Consultant
Dr. Gustavo L.A. Delendatti B.Sc (Hons), MAIG, Ph.D.Vice President of Exploration
Dr. Jakob Kløve KeidingChief Geologist

Contact

Address1300 South Boulevard, Unit D, Charlotte, North Carolina 28203, United States
Phone833 931 6330
Websitehttps://greenlandmines.com